155
Participants
Start Date
March 18, 2020
Primary Completion Date
March 3, 2022
Study Completion Date
June 9, 2026
PF-06801591
A monoclonal antibody (mAb) that blocks the interaction between PD-1 and PDL1/ PD-L2.
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City
"Мunicipal non-profit enterprise Zhytomyr Regional Oncology Dispensary of Zhytomyr Regional Council", Zhytomyr
Taipei Veterans General Hospital, Taipei
Seoul National University Bundang Hospital, Seongnam-si
Gachon University Gil Medical Center, Incheon
"Private Enterprise of Private Manufacturing Company Acinus, Medical and Diagnostic Center", Kirovohrad
"Medeya Sumy LLC", Sumy
"Municipal Non Profit enterprise of Sumy Regional Council Sumy Regional Clinical Oncology Center", Sumy
Communal Non-profit Enterprise City Clinical Hospital #4 of Dnipro City Council, Dnipro
"Llc Mdc Expert", Dnipro
Llc Medical Centre, Odesa
Municipal Non-profit Enterprise Odesa Regional Clinical Hospital of Odesa Regional Council, Odesa
Llc Lidermed, Odesa
"Municipal Non-profit Enterprise SubCarpathian Clinical Oncological Centre of Ivano-Frankivsk RC", Ivano-Frankivsk
Llc Medical Center Diamed, Uzhhorod
MNPE Central City Clinical Hospital of Uzhhorod City Council, Uzhhorod
Beijing Cancer hospital, Beijing
"State budgetary institution of healthcare of Yaroslavl region Clinical oncology hospital", Yaroslavl
"LLC Medical Center Magnit", Saint Petersburg
"Llc Mss", Saint Petersburg
North-West Medical Center, Saint Petersburg
"Road clinical clinic of JSC RZD", Saint Petersburg
"NS HI Road Clinical Hospital of JSC Russian Railways", Saint Petersburg
"Private Healthcare Institution Clinical Hospital RZD-Medicine of St. Petersburg", Saint Petersburg
"LLC Diagnostic center Energo", Saint Petersburg
"Private Medical Institution Euromedservice", Pushkin
Russian Research Centre for Radiology and Surgical Technologies, Saint Petersburg
Russian Scientific Center For Radiology and Surgical Technologies, Pesochny
Huashan Hospital Affiliated to Fudan University, Shanghai
Nanjing Drum Tower Hospital, Nanjing
Ars Medika Center, LLC, Kaliningrad
Klinika UZI 4D, LLC, Pyatigorsk
Chongqing Cancer Hospital, Chongqing
Medical University REAVIZ, Samara
Medical University REAVIZ, Samara
Evimed Llc, Chelyabinsk
Chelyabinsk Regional Clinical Centre of Oncology and Nuclear Medicine, Chelyabinsk
Enlimed Llc, Kopeysk
Orenburg Regional Clinical Oncological Dispensary, Orenburg
National Cancer Center Hospital, Chuo-ku
GBUZ Regional Clinical Hospital of Kaliningrad region, Kaliningrad
"Limited Liability Company MedX-ray International Group", Pliuty Village
Severance Hospital, Yonsei Univ. Health System, Seoul
Asan Medical Center, Seoul
Asklepion Medical Center, Khodosovka
"Medical centre Verum Limited Liability Company", Kyiv
Vita Сom LLC, Kyiv
"The State Institution Romodanov Neurosurgery Institute,", Kyiv
Lead Sponsor
Pfizer
INDUSTRY